The US launched a tariff investigation into Germany over what it called “persistent underpayment for innovative pharmaceutical products,” setting the stage for possible levies on its goods in retaliation.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-06-19/us-starts-section-301-probe-of-germany-over-pharmaceuticals-mqk73om2)